Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


GranuFlo Dialysis Cardiac Arrest

GranuFlo is an acidic concentrate product used in thousands of dialysis clinics nationwide which allows them to mix their own dialysate without storing heavy and expensive drums of liquid solution.

The maker, Fresenius Medical Care, serves as many as one-third of the 400,000 patients who receive dialysis each day. Unfortunately, Granuflo has been linked to dialysis complications that can cause serious heart problems such as Granuflo cardiac arrest.

Cardiac arrest, also known as cardiopulmonary arrest, occurs when an arrhythmia, or abnormal heart beat, causes the heart to stop beating. This is caused by a disruption of the heart’s electrical system, which is different from a heart attack.

Cardiac arrest often occurs suddenly and without warning. However, it is sometimes preceded by symptoms such as:

  • Chest pain
  • Dizziness
  • Shortness of breath
  • Fainting
  • Nausea or vomiting
  • Heart palpitations (fast or irregular heart beats)

Studies have shown that the improper use of dialysates like Granuflo can raise the occurrence of Granuflo dialysis cardiac arrest by as much as six times the normal rate.

Although Fresenius discovered these risks in 2010, they concealed the dangers until March of 2012, putting thousands of patients at risk. Lawyers are now helping those affected file claims for their loss.

If you or a loved one suffered dialysis cardiac arrest after using Granuflo, you may be entitled to substantial compensation. It is important to speak with a lawyer about your legal options. Contact us today.

Dialysis takes over the work of damaged or failed kidneys that can no longer cleanse the blood of toxic. Most dialysate solutions do so with acetic acid. However, Granuflo also contains sodium acetate, which is converted to bicarbonate by the patient’s tissue and liver. 

Without proper warning from Fresenius, Granuflo dialysate was often improperly mixed or patients were prescribed separate bicarbonates, causing their bicarbonate levels to increase. This can raise the risk of heart problems such as heart attack or Granuflo cardiac arrest.

Although Fresenius performed a year-long study in 2010 which showed improper mixing of their product could contribute to dialysis cardiac arrest, they hid these dangers from the FDA, outside doctors and the public. As a result, hundreds of thousands of patients were put at risk of severe heart injury or death.

Many of those affected by Granuflo cardiac arrest or the death of a loved one after dialysis have already filed lawsuits. Due to the amount of cases expected, a federal judicial panel recently recommended they be combined to a special Multi-District Litigation court. A lawyer can explain whether your case qualifies and how long you have to take action.

Before choosing a lawyer, make sure they are qualified for this type of lawsuit and have the resources and experience necessary to fight large drug companies. The DrugRisk Resource Center only recommends law firms that specialize in drug injuries and have handled Granuflo claims.

For more information on the research, warnings, side effects and litigation related to Granuflo, or to speak with a lawyer, contact us today. We are available 24 hours a day to provide help.